Global Bilirubin Oxidase Market Growth 2025-2031
Description
The global Bilirubin Oxidase market size is predicted to grow from US$ 3181 million in 2025 to US$ 6185 million in 2031; it is expected to grow at a CAGR of 11.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Bilirubin Oxidase (EC 1.3.3.5) is a copper-containing oxidoreductase that catalyzes the oxidation of bilirubin to produce biliverdin and water, while reducing oxygen to produce water, and participates in heme metabolism in the body. The enzyme has high substrate specificity, heat resistance and wide pH adaptability, and is widely used in medical diagnosis (such as serum bilirubin detection), biosensors (such as glucose detection) and environmental engineering (wastewater treatment). Its industrial preparation mainly comes from fungi (such as Myrothecium verrucaria) or genetic engineering recombinant expression.
United States market for Bilirubin Oxidase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Bilirubin Oxidase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Bilirubin Oxidase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Bilirubin Oxidase players cover Amano Enzyme Inc., SEKISUI Diagnostics, MP Biomedicals, OriGene, Creative Enzymes, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Bilirubin Oxidase Industry Forecast” looks at past sales and reviews total world Bilirubin Oxidase sales in 2024, providing a comprehensive analysis by region and market sector of projected Bilirubin Oxidase sales for 2025 through 2031. With Bilirubin Oxidase sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bilirubin Oxidase industry.
This Insight Report provides a comprehensive analysis of the global Bilirubin Oxidase landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bilirubin Oxidase portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bilirubin Oxidase market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bilirubin Oxidase and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bilirubin Oxidase.
This report presents a comprehensive overview, market shares, and growth opportunities of Bilirubin Oxidase market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Microbial Source
Genetic Engineering Recombinant Source
Segmentation by Application:
Medical Diagnosis
Environmental Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Amano Enzyme Inc.
SEKISUI Diagnostics
MP Biomedicals
OriGene
Creative Enzymes
Seebio
Toyobo
Rockland Inc
Nipro Corporation
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bilirubin Oxidase market?
What factors are driving Bilirubin Oxidase market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bilirubin Oxidase market opportunities vary by end market size?
How does Bilirubin Oxidase break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Bilirubin Oxidase (EC 1.3.3.5) is a copper-containing oxidoreductase that catalyzes the oxidation of bilirubin to produce biliverdin and water, while reducing oxygen to produce water, and participates in heme metabolism in the body. The enzyme has high substrate specificity, heat resistance and wide pH adaptability, and is widely used in medical diagnosis (such as serum bilirubin detection), biosensors (such as glucose detection) and environmental engineering (wastewater treatment). Its industrial preparation mainly comes from fungi (such as Myrothecium verrucaria) or genetic engineering recombinant expression.
United States market for Bilirubin Oxidase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Bilirubin Oxidase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Bilirubin Oxidase is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Bilirubin Oxidase players cover Amano Enzyme Inc., SEKISUI Diagnostics, MP Biomedicals, OriGene, Creative Enzymes, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Bilirubin Oxidase Industry Forecast” looks at past sales and reviews total world Bilirubin Oxidase sales in 2024, providing a comprehensive analysis by region and market sector of projected Bilirubin Oxidase sales for 2025 through 2031. With Bilirubin Oxidase sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bilirubin Oxidase industry.
This Insight Report provides a comprehensive analysis of the global Bilirubin Oxidase landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bilirubin Oxidase portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bilirubin Oxidase market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bilirubin Oxidase and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bilirubin Oxidase.
This report presents a comprehensive overview, market shares, and growth opportunities of Bilirubin Oxidase market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Microbial Source
Genetic Engineering Recombinant Source
Segmentation by Application:
Medical Diagnosis
Environmental Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Amano Enzyme Inc.
SEKISUI Diagnostics
MP Biomedicals
OriGene
Creative Enzymes
Seebio
Toyobo
Rockland Inc
Nipro Corporation
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bilirubin Oxidase market?
What factors are driving Bilirubin Oxidase market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bilirubin Oxidase market opportunities vary by end market size?
How does Bilirubin Oxidase break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
103 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Bilirubin Oxidase by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Bilirubin Oxidase by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.